SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cadus Pharmaceutical Corp. (KDUS)
An SI Board Since February 1998
Posts SubjectMarks Bans Symbol
1833 48 0 KDUS
Emcee:  Dave K Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
783Icahn Has 37.8% Cadus Pharmaceutical Stake,Says Shares Undervalued WASHINGTON -keokalani'nui-4/25/2002
78213D - Ichan up to 37.8% April 23, 2002 (Date of Event which Requimichael_f_murphy-4/25/2002
781Not really. But my opinion of the leverage has improved a ton. Lots of potentiscaram(o)uche-4/25/2002
780Has the news since Dec. (licensing deal for $500,000+ with a major pharma and thTomato-4/25/2002
779Guess that Janssen's Propulsid is targeted.A 5HT3 drug somewhat related to tbauke j deinum-4/25/2002
778Richard, One big seller today. I picked up some more.stockselect1-4/22/2002
777Cytometry 2002 Mar 1;47(3):183-91 Mixing small volumes for continuous high-thrscaram(o)uche-4/20/2002
776<i>The current treatments for acid reflux disease are proton pump inhibitoscaram(o)uche-4/19/2002
775<i>Our lead compound for treating lung cancer, designated AXM-570, has supscaram(o)uche-4/19/2002
774Even though it's listed as "in press" for 2001, there's a new scaram(o)uche-4/19/2002
773web pages spruced up, they must be planning to stick around!!........ axiombio.scaram(o)uche-4/19/2002
772Tuesday April 9, 7:04 am Eastern Time Press Release SOURCE: Axiom Biotechnologiescaram(o)uche-4/9/2002
771Wo! The Biacore influence must have ebbed. Thanks! That was the figure I was scaram(o)uche-4/3/2002
770Ask, and it shall be given <g>: Dear Mr (Tomato): Cadus owns 25.8% of AxiTomato-4/3/2002
769Tuesday April 2, 7:01 am Eastern Time Press Release SOURCE: Axiom Biotechnologiescaram(o)uche-4/2/2002
768>> I hear McDonald's might be still serving super hot coffee << scaram(o)uche-3/29/2002
767Maybe a lawsuit would have been worse? Punitive damages? More atty. fees? GueTomato-3/29/2002
766How do I get one of those arbitration thingies? They seem to pay pretty well. scaram(o)uche-3/29/2002
765nothing here to worry about, or, downside, lend much incentive..... <i>Atscaram(o)uche-3/29/2002
764OK, no litigation, no arbitration, subsidiary in place....... Shareholder equitscaram(o)uche-3/29/2002
763ah, that's no fun! they took the arbitration expense Q4 2001. Net loss $44scaram(o)uche-3/29/2002
762NUMBER OF SHARES scaram(o)uche-3/29/2002
761a "sensational!" followed by an "ugh!"...... <i>EMPLOscaram(o)uche-3/29/2002
76010-K is out. I'll post bits and pieces as I go...... <i>GENERAL scaram(o)uche-3/29/2002
759An Axiom/Arena competitive project?? (note collaborations with Solvay and UCB)..scaram(o)uche-3/28/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News